Effect of tacrolimus derivatives on immunosuppression

被引:6
作者
Choi, DuBok [2 ]
Cho, Hoon [1 ]
机构
[1] Chosun Univ, Dept Polymer Sci & Engn, Kwangju 501759, South Korea
[2] Cho Dang Univ, Dept Environm Hlth, Chungnam 534800, South Korea
关键词
Tacrolimus (FK506); prodrug; immunosuppressant; inhibitive action of skin grafting rejection; and Freund's complete adjuvant arthritis; CREMOPHOR-EL; STREPTOMYCES; CYCLOSPORINE; ADVANTAGES; VEHICLE; FK-506;
D O I
10.1007/s12272-009-1411-y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, the effects of the FK506-mPEG on immune cell activity, skin grafting rejection, and Freund's complete adjuvant arthritis were investigated. The proliferation of T cells was inhibited with increase with the FK506 and FK506-mPEG concentrations. FK506 and FK506-mPEG at concentrations between 0.01 nM and 1000 nM had very similar effects on the proliferation of the T cells. On the other hand, in the case of the proliferation of T cells by calcium ionophore A23187 (1 mu M), when the FK506-mPEG concentration was increased from 0.01 to 1000 mM, the proliferation was decreased from 90.8 to 40.3%. This was 1.8-fold higher than that of paramethoxyamphetamine (PMA). The inhibitory effect of FK506-mPEG on mast cell proliferation was higher than that of FK506. When B cells were cultured for 7 days in basal medium with no pokeweed mitogen (PWM), the IgG production was 156.2 ng/mL. On the other hand, in the case of the same treatment with 0.25% of PWM, it was 876.4 ng/mL. This is about 5.6-fold higher than with no PWM. These results show that FK506-mPEG may be practically applicable as a prodrug for the immunosuppressant FK506.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 50 条
[31]   Effect of telaprevir on the metabolism and hepatic uptake of tacrolimus (FK506) [J].
Oda, Kazuo ;
Yamano, Katsuhiro .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (09) :501-512
[32]   Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients [J].
Wen, X. ;
Casey, M. J. ;
Santos, A. H. ;
Hartzema, A. ;
Womer, K. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) :3202-3211
[33]   Metabonomic Analysis of Serum Metabolites in Kidney Transplant Recipients With Cyclosporine A- or Tacrolimus-Based Immunosuppression [J].
Kim, Chan-Duck ;
Kim, Eun-Young ;
Yoo, Hanna ;
Lee, Jae Won ;
Ryu, Do Hyun ;
Noh, Dong Woo ;
Park, Sun-Hee ;
Kim, Yong-Lim ;
Hwang, Geum-Sook ;
Kwon, Tae-Hwan .
TRANSPLANTATION, 2010, 90 (07) :748-756
[34]   Tacrolimus-loaded Drug Delivery Systems in Vascularized Composite Allotransplantation: Lessons and Opportunities for Local Immunosuppression [J].
Ben Brahim, Bilal ;
Arenas Hoyos, Isabel ;
Zhang, Lei ;
Voegelin, Esther ;
Olariu, Radu ;
Rieben, Robert .
TRANSPLANTATION, 2025, 109 (01) :142-152
[35]   Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation [J].
Helmschrott, Matthias ;
Rivinius, Rasmus ;
Ruhparwar, Arjang ;
Schmack, Bastian ;
Erbel, Christian ;
Gleissner, Christian A. ;
Akhavanpoor, Mohammadreza ;
Frankenstein, Lutz ;
Ehlermann, Philipp ;
Bruckner, Tom ;
Katus, Hugo A. ;
Doesch, Andreas O. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :1217-1224
[36]   Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver [J].
Takeichi, Takayuki ;
Uemoto, Shinji ;
Minamiguchi, Sachiko ;
Takeyoshi, Izumi ;
Inomata, Yukihiro ;
Tanaka, Koichi ;
Kobayashi, Eiji .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (45) :5712-5715
[37]   Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: Effect on spinally grafted human neural precursor survival [J].
Sevc, Juraj ;
Goldberg, Danielle ;
van Gorp, Sebastiaan ;
Leerink, Marjolein ;
Juhas, Stefan ;
Juhasova, Jana ;
Marsala, Silvia ;
Hruska-Plochan, Marian ;
Hefferan, Michael P. ;
Motlik, Jan ;
Rypacek, Frantisek ;
Machova, Ludka ;
Kakinohana, Osamu ;
Santucci, Camila ;
Johe, Karl ;
Lukacova, Nadezda ;
Yamada, Kazuhiko ;
Bui, Jack D. ;
Marsala, Martin .
EXPERIMENTAL NEUROLOGY, 2013, 248 :85-99
[38]   Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia [J].
Knight, Richard J. ;
Graviss, Edward A. ;
Nguyen, Duc T. ;
Kuten, Samantha A. ;
Patel, Samir J. ;
Gaber, Lillian ;
Gaber, A. Osama .
CLINICAL TRANSPLANTATION, 2018, 32 (06)
[39]   Tacrolimus with mycophenotate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results [J].
Kaczmarek, Ingo ;
Zaruba, Marc-Michael ;
Beiras-Fernandez, Andres ;
Reimann, Ricarda ;
Nickel, Thomas ;
Grinninger, Carola ;
Sadoni, Sebastian ;
Hagl, Christian ;
Meiser, Bruno .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (03) :277-284
[40]   Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506) [J].
Chen, YW ;
Smith, ML ;
Sheets, MP ;
Ballaron, SJ ;
Trevillyan, JM ;
Fey, TA ;
Gauvin, DM ;
Kolano, R ;
Pong, MS ;
Hsieh, GC ;
Bauch, J ;
Marsh, K ;
Carter, G ;
Luly, J ;
Djuric, S ;
Mollison, KW .
CLINICAL IMMUNOLOGY, 1999, 90 (01) :133-140